Whales with a lot of money to spend have taken a noticeably bullish stance on Novo Nordisk.
Looking at options history for Novo Nordisk (NYSE:NVO) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 62% of the investors opened trades with bullish expectations and 37% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $83,110 and 6, calls, for a total amount of $233,083.
Expected Price Movements
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $40.0 to $120.0 for Novo Nordisk during the past quarter.
Insights into Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Novo Nordisk's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Novo Nordisk's whale activity within a strike price range from $40.0 to $120.0 in the last 30 days.
Novo Nordisk Option Activity Analysis: Last 30 Days

Significant Options Trades Detected:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
---|
NVO | CALL | TRADE | NEUTRAL | 01/16/26 | $120.00 | $51.8K | 133 | 32 |
NVO | CALL | SWEEP | BULLISH | 01/19/24 | $87.50 | $49.0K | 970 | 30 |
NVO | PUT | SWEEP | BULLISH | 02/16/24 | $115.00 | $45.1K | 35 | 56 |
NVO | CALL | SWEEP | BEARISH | 01/17/25 | $40.00 | $40.4K | 70 | 16 |
NVO | PUT | TRADE | BULLISH | 01/16/26 | $105.00 | $37.9K | 11 | 26 |
About Novo Nordisk
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Following our analysis of the options activities associated with Novo Nordisk, we pivot to a closer look at the company's own performance.
Current Position of Novo Nordisk
- With a trading volume of 1,321,941, the price of NVO is down by -0.1%, reaching $106.24.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 14 days from now.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Novo Nordisk, Benzinga Pro gives you real-time options trades alerts.
有大量资金可以花的大户对诺和诺德采取了明显的看涨立场。
查看诺和诺德(纽约证券交易所代码:NVO)的期权历史记录,我们发现了8笔交易。
如果我们考虑每笔交易的具体情况,可以准确地说,62%的投资者以看涨的预期开启交易,37%的投资者持看跌预期。
在已发现的全部交易中,有2笔是看跌期权,总额为83,110美元;6笔看涨期权,总额为233,083美元。
预期的价格走势
分析这些合约的交易量和未平仓合约,看来大型企业一直在关注诺和诺德在过去一个季度的价格范围从40.0美元到120.0美元不等。
对交易量和未平仓合约的见解
查看交易量和未平仓合约是对股票进行尽职调查的一种有见地的方式。
这些数据可以帮助您跟踪Novo Nordisk期权在给定行使价下的流动性和利息。
下面,我们可以分别观察过去30天内诺和诺德所有大户活动的看涨和看跌期权交易量和未平仓合约的变化,其行使价在40.0美元至120.0美元之间。
诺和诺德期权活动分析:过去 30 天
检测到的重大期权交易:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
---|
NVO | CALL | TRADE | NEUTRAL | 01/16/26 | $120.00 | $51.8K | 133 | 32 |
NVO | CALL | SWEEP | BULLISH | 01/19/24 | $87.50 | $49.0K | 970 | 30 |
NVO | PUT | SWEEP | BULLISH | 02/16/24 | $115.00 | $45.1K | 35 | 56 |
NVO | CALL | SWEEP | BEARISH | 01/17/25 | $40.00 | $40.4K | 70 | 16 |
NVO | PUT | TRADE | BULLISH | 01/16/26 | $105.00 | $37.9K | 11 | 26 |
关于 Novo Nordisk
Novo Nordisk拥有全球品牌糖尿病治疗市场约三分之一的份额,是全球领先的糖尿病护理产品提供商。该公司总部位于丹麦,生产和销售各种人类和现代胰岛素、可注射的糖尿病治疗药物,例如 GLP-1 疗法、口服抗糖尿病药物和肥胖疗法。Novo还有一个生物制药板块(约占收入的10%),专门从事血友病和其他疾病的蛋白质疗法。
在分析了与Novo Nordisk相关的期权活动之后,我们将转向仔细研究公司自身的表现。
诺和诺德的当前位置
与仅交易股票相比,期权是一种风险更高的资产,但它们具有更高的盈利潜力。严肃的期权交易者通过每天进行自我教育、扩大交易规模、遵循多个指标以及密切关注市场来管理这种风险。
如果您想随时了解Novo Nordisk的最新期权交易,Benzinga Pro会为您提供实时期权交易提醒。